{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:57:43Z","timestamp":1791561463184,"version":"4.3.4"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"38","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,9]]},"DOI":"10.1093\/eurheartj\/ehag792","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:16:11Z","timestamp":1789672571000},"page":"5327-5333","source":"Crossref","is-referenced-by-count":0,"title":["ESC Guidelines, mechanisms of myocarditis, novel insights into treatment with mineralcorticoid receptor antagonists, cardiac glycosides, and GLP-1 receptor agonists"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-411X","authenticated-orcid":false,"given":"Filippo","family":"Crea","sequence":"first","affiliation":[{"name":"Center of Excellence of Cardiovascular Sciences, Ospedale Isola Tiberina \u2013 Gemelli Isola , Rome ,","place":["Italy"]},{"name":"Catholic University of the Sacred Heart , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"2026100911293609500_ehag792-B1","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1093\/eurheartj\/ehag100","article-title":"2026 ESC Guidelines for the management of heart failure","volume":"47","author":"K\u00f8ber","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B2","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1093\/eurheartj\/ehag173","article-title":"Cardiac involvement in parasitic infections","volume":"47","author":"Nunes","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B3","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1093\/eurheartj\/ehag426","article-title":"Albuminuria and heart failure","volume":"47","author":"Butler","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B4","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1093\/eurheartj\/ehag450","article-title":"Brain mineralocorticoid receptor activation and antagonism in heart failure with preserved ejection fraction: a hypothesis","volume":"47","author":"Lund","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B5","doi-asserted-by":"publisher","first-page":"5504","DOI":"10.1093\/eurheartj\/ehag318","article-title":"Haemodynamic diagnosis of pulmonary vascular disease in heart failure","volume":"47","author":"Naeije","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B6","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.1093\/eurheartj\/ehag511","article-title":"Great debate: medical treatment of heart failure with reduced ejection fraction will rely on four foundational drugs","volume":"47","author":"Cleland","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B7","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1093\/eurheartj\/ehag311","article-title":"Sex differences in pharmacological treatment of heart failure: a meta-analysis of randomized trials","volume":"47","author":"van der Bijl","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B8","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1093\/eurheartj\/ehag559","article-title":"Do women and men have equal benefits from heart failure medications?","volume":"47","author":"Linde","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B9","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.1093\/eurheartj\/ehag385","article-title":"Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in patients with heart failure: the DECISION trial","volume":"47","author":"van der Meer","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B10","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1093\/eurheartj\/ehag629","article-title":"Staging a comeback for digitalis","volume":"47","author":"Stevenson","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf459","article-title":"Mineralocorticoid receptor antagonists and hyperkalaemia: predictable, preventable, manageable, and reversible","author":"Marques","year":"2025","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B12","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/eurheartj\/ehae863","article-title":"Immunometabolic switch in hypertension: how dendritic cell mineralocorticoid receptors drive Th17 polarization and blood pressure control","volume":"46","author":"Mikolajczyk","year":"2025","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B13","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1093\/eurheartj\/ehae670","article-title":"Dendritic cell mineralocorticoid receptor controls blood pressure by regulating T helper 17 differentiation: role of the Plc\u03b21\/4-Stat5-NF-\u03baB pathway","volume":"46","author":"Wang","year":"2025","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B14","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/eurheartj\/ehae040","article-title":"Mineralocorticoid receptor antagonists for the prevention of atrial fibrillation in patients with and without heart failure: one more beneficial effect?","volume":"45","author":"Zurkan","year":"2024","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B15","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/eurheartj\/ehad811","article-title":"Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis of clinical trials","volume":"45","author":"Oraii","year":"2024","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B16","doi-asserted-by":"publisher","first-page":"5558","DOI":"10.1093\/eurheartj\/ehag440","article-title":"Blood aldosterone concentrations and effects of mineralocorticoid receptor antagonists in heart failure","volume":"47","author":"Rao","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B17","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.1093\/eurheartj\/ehag603","article-title":"Mineralocorticoid inhibition in heart failure: does one size fit all?","volume":"47","author":"Brown","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf866","article-title":"New insights into the management of fulminant myocarditis","author":"Cooper","year":"2025","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B19","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1093\/eurheartj\/ehaf782","article-title":"Improving understanding and management of acute heart failure, myocarditis, pericarditis, amyloidosis, mitochondrial cardiomyopathies, hypertrophic cardiomyopathy, and takotsubo syndrome","volume":"46","author":"Crea","year":"2025","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf671","article-title":"Fulminant myocarditis: outcome predictors in an international cohort study","author":"Majunke","year":"2025","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B21","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1093\/eurheartj\/ehaf593","article-title":"Myocarditis after COVID-19, sepsis-induced cardiomyopathy, and haemodynamic assessment of heart failure: focus on the myocardium","volume":"46","author":"Crea","year":"2025","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B22","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","article-title":"2025 ESC Guidelines for the management of myocarditis and pericarditis","volume":"46","author":"Schulz-Menger","year":"2025","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B23","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/eurheartj\/ehaf503","article-title":"Immune checkpoint inhibitor myocarditis-a score to tell you more","volume":"47","author":"Herrmann","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B24","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/eurheartj\/ehaf315","article-title":"Immune checkpoint inhibitor-associated myocarditis: a novel risk score","volume":"47","author":"Power","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B25","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1093\/eurheartj\/ehae220","article-title":"Myocarditis diagnosis: harnessing order amongst heterogeneity through collaboration","volume":"45","author":"Kafil","year":"2024","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B26","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1093\/eurheartj\/ehae169","article-title":"Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry","volume":"45","author":"Caforio","year":"2024","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B27","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1093\/eurheartj\/ehae143","article-title":"Charting new frontiers in paediatric cardiomyopathies: lessons from the ESC EORP Cardiomyopathy and Myocarditis Registry in paediatric age","volume":"45","author":"Sabatino","year":"2024","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B28","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1093\/eurheartj\/ehag105","article-title":"Soluble ST2 drives fulminant myocarditis progression via the IGF2R-YY1 mitochondrial axis","volume":"47","author":"Zhuang","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B29","doi-asserted-by":"publisher","first-page":"5590","DOI":"10.1093\/eurheartj\/ehag142","article-title":"Soluble ST2 beyond a biomarker: a pathogenic driver and therapeutic target in fulminant myocarditis","volume":"47","author":"Kania","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B30","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1093\/eurheartj\/ehag483","article-title":"Weight loss, exercise haemodynamics, and health status with incretin therapy for heart failure with preserved ejection fraction and obesity","volume":"47","author":"Pandey","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B31","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.1093\/eurheartj\/ehag379","article-title":"Digitoxin in heart failure with reduced ejection fraction according to atrial fibrillation status: the DIGIT-HF trial","volume":"47","author":"Bavendiek","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B32","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.1093\/eurheartj\/ehag664","article-title":"Hypokalaemia and hyperkalaemia in heart failure: risk factor or risk marker?","volume":"47","author":"Lund","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B33","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.1093\/eurheartj\/ehag341","article-title":"Optimal serum potassium concentrations in heart failure: an individual patient data meta-analysis","volume":"47","author":"Ono","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B34","doi-asserted-by":"publisher","first-page":"5604","DOI":"10.1093\/eurheartj\/ehag666","article-title":"Potassium in heart failure: prognostic associations and clinical implications","volume":"47","author":"Ono","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B35","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.1093\/eurheartj\/ehag676","article-title":"The heart, sex hormones, and ageing: of women and men","volume":"47","author":"\u010culi\u0107","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100911293609500_ehag792-B36","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf922","article-title":"Sex-specific cardiac ageing and sympathetic compensation: a translational study","author":"Haider","year":"2025","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/38\/5327\/71788653\/ehag792.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/38\/5327\/71788653\/ehag792.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:29:44Z","timestamp":1791559784000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/38\/5327\/8898693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":36,"journal-issue":{"issue":"38","published-online":{"date-parts":[[2026,10,9]]},"published-print":{"date-parts":[[2026,10,9]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag792","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,7]]},"published":{"date-parts":[[2026,10,7]]}}}